Advertisement

Intense Pulsed Light Treatment for Rosacea

  • Brent Martin
  • Vineet Mishra
  • Daniel P. Friedmann
Chapter
  • 334 Downloads

Abstract

Rosacea is a chronic inflammatory cutaneous disorder of the face involving blood vessels and pilosebaceous units that can lead to psychosocial impairment and functional disability. While medical management has been aimed at reducing the severity of papulopustular lesions and flushing episodes, light and laser therapy has been the mainstay for targeting chronic erythema and telangiectasias associated with the condition. The purpose of this chapter is to highlight the use of IPL as a safe and effective treatment option for rosacea.

Keywords

IPL Inflammatory Rosacea Erythematotelangiectatic Rosacea 

References

  1. 1.
    Bamford JTM, Gessert CE, Renier CM, et al. Childhood stye and adult rosacea. J Am Acad Dermatol. 2006;55:951–5.PubMedGoogle Scholar
  2. 2.
    Halder RM, Brooks HL, Callender VD. Acne in ethnic skin. Dermatol Clin. 2003;21:609–15.PubMedGoogle Scholar
  3. 3.
    Kyriakis KP, Palamaras I, Terzoudi S, et al. Epidemiologic aspects of rosacea. J Am Acad Dermatol. 2005;53:918–9.PubMedGoogle Scholar
  4. 4.
    Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69:S27–35.PubMedGoogle Scholar
  5. 5.
    Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of Rosacea. J Am Acad Dermatol. 2002;46:584–7.Google Scholar
  6. 6.
    Greaves MW, Burova EP. Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol. 1997;8:91–100.Google Scholar
  7. 7.
    Crawford GH, Pelle MT, James WD. Rosacea: I. etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327–41.PubMedGoogle Scholar
  8. 8.
    Powell FC. Rosacea. N Engl J Med. 2005;352:793–803.PubMedGoogle Scholar
  9. 9.
    Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg. 1998;14:241–53.Google Scholar
  10. 10.
    Steinhoff M, Schauber J. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69:S15–26.PubMedGoogle Scholar
  11. 11.
    Cribier B. Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Ann Dermatol Venereol. 2011;138:S184–91.PubMedGoogle Scholar
  12. 12.
    Goldman MP, Weiss RA, Weiss MA. Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg. 2005;31:1179–87.PubMedGoogle Scholar
  13. 13.
    Ross EV, Smirnov M, Pankratov M, et al. Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: some theoretical and practical comparisons. Dermatol Surg. 2005;31:1188–98.PubMedGoogle Scholar
  14. 14.
    Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32:78–87.PubMedGoogle Scholar
  15. 15.
    Wat H, Wu DC, Rao J, et al. Application of intense pulsed light in the treatment of dermatologic disease: a systematic review. Dermatol Surg. 2014;40:359–77.PubMedGoogle Scholar
  16. 16.
    Mark KA, Sparacio RM, Voigt A, et al. Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment. Dermatol Surg. 2003;29:600–4.PubMedGoogle Scholar
  17. 17.
    Taub AF. Treatment of rosacea with intense pulsed light. J Drugs Dermatol. 2003;2:254–9.PubMedGoogle Scholar
  18. 18.
    Schroeter CA, Haaf-von Below S, Neumann HAM. Effective treatment of rosacea using intense pulsed light systems. Dermatol Surg. 2005;31:1285–9.PubMedGoogle Scholar
  19. 19.
    Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg. 2007;33:449–54.PubMedGoogle Scholar
  20. 20.
    Papageorgiou P, Clayton W, Norwood S, et al. Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results. Br J Dermatol. 2008;159:628–32.PubMedGoogle Scholar
  21. 21.
    Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea. Dermatol Surg. 2009;35:920–8.PubMedGoogle Scholar
  22. 22.
    Nymann P, Hedelund L, Haedersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2010;24:143–6.PubMedGoogle Scholar
  23. 23.
    Kassir R, Kolluru A, Kassir M. Intense pulsed light for the treatment of rosacea and telangiectasias. J Cosmet Laser Ther. 2011;13:216–22.PubMedGoogle Scholar
  24. 24.
    Hassan H, Lowe NJ, Barlow R, et al. Four methods of evaluation of facial erythema and pigment treated with intense pulsed light or cream. J Cosmet Laser Ther. 2012;87:200–6.Google Scholar
  25. 25.
    Tanghetti EA. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece. Lasers Surg Med. 2012;44:97–102.PubMedGoogle Scholar
  26. 26.
    Lim HS, Lee SC, Won YH, et al. The efficacy of intense pulsed light for treating erythematotelangiectatic rosacea is related to severity and age. Ann Dermatol. 2014;26:491–5.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Liu J, Liu J, Ren Y, et al. Comparative efficacy of intense pulsed light for different erythema associated with rosacea. J Cosmet Laser Ther. 2014;16:324–7.PubMedGoogle Scholar
  28. 28.
    Piccolo D, Di Marcantonio D, Crisman G, et al. Unconventional use of intense pulsed light. Biomed Res Int. 2014;2014:618206.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Belenky I, Tagger C, Bingham A. Intense pulsed light pulse configuration manipulation can resolve the classic conflict between safety and efficacy. J Drugs Dermatol. 2015;14:1255–60.PubMedGoogle Scholar
  30. 30.
    Gold MH, Biron JA, Sensing W. Facial skin rejuvenation by combination treatment of IPL followed by continuous and fractional radiofrequency. J Cosmet Laser Ther. 2016;18:2–6.PubMedGoogle Scholar
  31. 31.
    Balzani A, Orfaniotis G, Lazzeri D, et al. Efficacy of a novel optimized pulsed light source (MaxG) for the treatment of facial vascular lesions. Photomed Laser Surg. 2017;35:12–7.PubMedGoogle Scholar
  32. 32.
    Handler MZ, Bloom BS, Goldberg DJ. IPL vs PDL in treatment of facial erythema: a split-face study. J Cosmet Dermatol. 2017;16:450–3.PubMedGoogle Scholar
  33. 33.
    Kim BY, Moon HR, Ryu HJ. Comparative efficacy of short-pulsed intense pulsed light and pulsed dye laser to treat rosacea. J Cosmet Laser Ther. 2018:1–6.  https://doi.org/10.1080/14764172.2018.1528371.
  34. 34.
    Tsunoda K, Akasaka K, Akasaka T, et al. Successful treatment of erythematotelangiectatic rosacea with intense pulsed light: report of 13 cases. J Dermatol. 2018;45:1113–6.PubMedGoogle Scholar
  35. 35.
    Angermeier MC. Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther. 1999;1:95–100.PubMedGoogle Scholar
  36. 36.
    Clementoni MT, Gilardino P, Muti GF. Facial teleangectasias: our experience in treatment with IPL. Lasers Surg Med. 2005;37:9–13.PubMedGoogle Scholar
  37. 37.
    Clementoni MT, Gilardino P, Muti GF, et al. Intense pulsed light treatment of 1,000 consecutive patients with facial vascular marks. Aesthet Plast Surg. 2006;30:226–32.Google Scholar
  38. 38.
    Fodor L, Peled IJ, Rissin Y, et al. Using intense pulsed light for cosmetic purposes: our experience. Plast Reconstr Surg. 2004;113:1789–95.PubMedGoogle Scholar
  39. 39.
    Myers P, Bowler P, Hills S. A retrospective study of the efficacy of intense pulsed light for the treatment of dermatologic disorders presenting to a cosmetic skin clinic. J Cosmet Dermatol. 2005;4:262–6.PubMedGoogle Scholar
  40. 40.
    Lane JE, Khachemoune A. Use of intense pulsed light to treat refractory granulomatous rosacea. Dermatol Surg. 2010;36:571–3.PubMedGoogle Scholar
  41. 41.
    Liu J, Zhou BR, Wu D, et al. Sequential delivery of intense pulsed light and long-pulse 1.064-nm neodymium-doped yttrium aluminum garnet laser shows better effect in the treatment of facial telangiectasias than using them separately. G Ital Dermatol Venereol. 2017;152:1–7.PubMedGoogle Scholar
  42. 42.
    Taub AF, Devita EC. Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency. J Clin Aesthet Dermatol. 2008;1:37–40.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Munavalli GS, Weiss RA, Halder RM. Photoaging and nonablative photorejuvenation in ethnic skin. Dermatol Surg. 2005;31:1250–60.PubMedGoogle Scholar
  44. 44.
    Friedmann DP, Goldman MP, Fabi SG, et al. Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea. J Cosmet Dermatol. 2016;15:407–12.PubMedGoogle Scholar
  45. 45.
    Vissing AE, Dierickx C, Karmisholt KE, et al. Topical brimonidine reduces IPL-induced erythema without affecting efficacy: a randomized controlled trial in patients with facial telangiectasias. Lasers Surg Med. 2018;50:1002–9.PubMedGoogle Scholar
  46. 46.
    Greve B, Raulin C. Professional errors caused by lasers and intense pulsed light technology in dermatology and aesthetic medicine: preventive strategies and case studies. Dermatol Surg. 2002;28:156–61.PubMedGoogle Scholar
  47. 47.
    Sperber BR, Walling HW, Arpey CJ, et al. Vesiculobullous eruption from intense pulsed light treatment. Dermatol Surg. 2005;31:345–8.PubMedGoogle Scholar
  48. 48.
    Hammes S, Karsai S, Metelmann HR, et al. Treatment errors resulting from use of lasers and IPL by medical laypersons: results of a nationwide survey. J Dtsch Dermatol Ges. 2013;11:149–56.PubMedGoogle Scholar
  49. 49.
    Ricci LH, Navajas SV, Carneiro PR, et al. Ocular adverse effects after facial cosmetic procedures: a review of case reports. J Cosmet Dermatol. 2015;14:145–51.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Brent Martin
    • 1
  • Vineet Mishra
    • 2
  • Daniel P. Friedmann
    • 3
  1. 1.Department of DermatologyUC Irvine HealthIrvineUSA
  2. 2.Department of DermatologyMohs Surgery, and Vascular Surgery, Scripps ClinicSan DiegoUSA
  3. 3.Westlake Dermatology Clinical Research CenterWestlake Dermatology and Cosmetic SurgeryAustinUSA

Personalised recommendations